Last Chance to Register for Free Webinar: Learn Latest Insights About Bispecific Antibody

October 11 17:18 2021
Don’t miss the free webinar on bsAb research on Oct. 14! Creative Biolabs announces the new live webinar, inviting Dr. Archana Thakur and Dr. Luca Varani to share the latest research on how bsAbs can better kill tumors and neutralize wild-type SARS-CoV-2 variants.

New York, USA – October 11, 2021 – In order to overcome the limitations of therapeutic antibodies and enhance their efficacy, various engineering and modification approaches have been devised and applied to the conventional immunoglobulin molecular format. Arguably one of the most prominent of these approaches is the bispecific antibody (bsAb).

By July 2021, 3 bsAbs have been licensed for commercial use by the FDA, and there are approximately 150 bsAb programs in clinical trials. They are gaining traction in a range of therapeutic fields depending on the target mechanism, with oncology and inflammation being the most developed.

To further promote the research on bsAbs, Creative Biolabs has invited 2 brilliant scientists, Dr. Archana Thakur from University of Virginia and Dr. Luca Varani from Università della Svizzera italiana, to share their latest research on bsAbs, hoping to discuss more about the current challenges, potential solutions, and future directions of bsAb development.

More Information:

Webinar Title: Harnessing the Power of Bispecific Antibodies

Time: 10AM EDT | 4PM CEST, October 14, 2021

Charge: Free


• 2 exciting discussions, about 30 min per presentation
• Q&A session to answer , about 10-15 min

What to Expect from the Webinar:

1. Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells

• The design of bsAb armed metabolically enhanced headless CAR T cells (hCART)
• The generation of bsAb armed metabolically enhanced hCART
• The efficacy of bsAb armed metabolically enhanced hCART in preclinical studies

2. Bispecific Antibody Protects from SARS-CoV-2 Variants of Concern and Prevents Viral Escape in Mice

• The development of the bispecific IgG1-like molecule (CoV-X2)
• CoV-X2 neutralizes wild-type SARS-CoV-2 and its variants in preclinical studies
• CoV-X2 protects mice from infection and suppresses viral escape

Join us for this free-to-attend live webinar series providing you with valuable information on the latest bsAb technologies, methodologies and solutions, and feel free to take this great opportunity to put your questions to the scientists, which might illuminate your ongoing or next bsAb research!

Don’t worry if you are not available on Oct. 14. You can register now and will get the email about the webinar recording. More information can be found at

About Creative Biolabs

Creative Biolabs has been dedicated to offering services on antibody discovery, engineering, production, and analysis for years. The bispecific antibody (bsAb) team has gathered a collective of experienced scientists committed to providing high-quality services to customers all over the world, covering bsAb design, purification, engineering, manufacturing and bsAb analysis service. With the cutting-edge platforms and methods, a comprehensive list of BsAb products is also available.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States